Custom Search


Portfolio of Gene Editing (CRISPR) Stocks

Here are 4 gene editing stocks that use CRISPR technology.

Portfolio of Gene Editing (CRISPR) Stocks
Stock
Price Quote & Dividend
1-Yr Price Chart
Crispr Therapeutics
Editas Medicine
Intellia Therapeutics 
Vertex Pharmaceuticals
Price data from Quandl.


To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the returns table and chart below. Portfolio values are computed using monthly closes for from Quandl.

All 4 are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each at its closing weekly price for the current date in 2017.


Portfolio of Gene Editing (CRISPR) Stocks - Return Results
Portfolio:
Portfolio of Gene Editing (CRISPR) Stocks
Start date:
Jun-24-2017
Start value:
$10,000
End date:
Jun-24-2018
End value:
$23,268
Number prices
13
Minimum value occurred on Jun-30-2017
$10,000
Maximum value occurred on May-31-2018
$23,685
Total gain or loss (Start date to End date)
132.68%
Annualized gain or loss (Start date to End date)
132.68%
Total dollar value on End date of a $10,000 purchase made on Start date
$23,268
Average percent return for all possible buy/sell combinations
32.33%
Number returns
78
Number profitable returns (Winners)
59
Percent profitable returns
75.64%
Number unprofitable returns (Losers)
19
Percent unprofitable returns
24.36%
Winners to losers ratio
3.11
Stock Return Calculator





Related Articles

Portfolio of Biotech Stocks: Cancer
Portfolio of Gene Editing Stocks
Portfolio of Gene Sequencing Stocks
Portfolio of Gene Therapy Stocks
Portfolio of Genetic Testing Stocks
Portfolio of Genomics Stocks
Portfolio of Personalized Medicine Stocks
Portfolio of Stem Cell Stocks
Portfolio of Synthetic Biology Stocks